Menu Search
Equities

Batm Advanced Communications Ltd

BAV:STU

Batm Advanced Communications Ltd

Actions
  • Price (EUR)0.176
  • Today's Change-0.001 / -0.56%
  • Shares traded0.00
  • 1 Year change-30.16%
  • Beta--
Data delayed at least 15 minutes, as of Apr 30 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BATM Advanced Communications Ltd. is an Israel-based company engaged in the development, production and marketing of medical products, as well as data communication products. The Company has two operating divisions: Telecommunications and BATM Medical. The Telecommunications division develops and offers telecom network solutions, IP surveillance solutions, software services and Cyber Security solutions. The Telecommunications offers its products to telecom operators in developed markets. BATM Medical is a manufacturer and developer of laboratory diagnostics, including in-vitro diagnostic systems and reagents to detect viral infections, to diagnose immune system diseases and for the measurement of human hormone responses. BATM Medical, which focuses on developing countries in Eastern Europe and Asia, also manufactures sterilizers and medical waste management solutions, and distributes brands of other diagnostic equipment suppliers to emerging market countries.

  • Revenue in GBP (TTM)98.34m
  • Net income in GBP-154.52k
  • Incorporated1992
  • Employees980.00
  • Location
    Batm Advanced Communications Ltd4, Ha'harash Street, P.O.B. 7318HOD HASHARON 4524075IsraelISR
  • Phone+972 98662525
  • Fax+972 98662500
  • Websitehttps://www.batm.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.